EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS) EBX-102-02 demonstrated clinically meaningful ...

Celebrate Nowruz 2025 on March 19, marking the Persian New Year and the arrival of spring. Discover traditions, quotes, and ...

Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune status SAN ...